BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem Cells - StreetInsider.com (subscription)

BioLineRx (BLRX) Issued US Patent Covering BL-8040 to Obtain Stem CellsStreetInsider.com (subscription)BioLineRx (Nasdaq: BLRX) announced that an Issue Notification has been received from the United States Patent and Trademark Office (USPTO) for US Patent No. 8,455,450, which claims the use of BL-8040 s composition for obtaining hematopoietic and more read more

http://blog.zandcell.com/biolinerx-blrx-issued-us-patent-covering-bl-8040-to-obtain-stem-cells-streetinsider-com-subscription/?utm_source=rss&utm_medium=rss&utm_campaign=biolinerx-blrx-issued-us-patent-covering-bl-8040-to-obtain-stem-cells-streetinsider-com-subscription